Clorox Navigates Cyberattack Fallout, Boosts Margins & Refreshes Board

Ticker: CLX · Form: DEF 14A · Filed: 2025-10-07T00:00:00.000Z

Sentiment: mixed

Topics: Consumer Staples, Corporate Governance, Executive Compensation, Cybersecurity Risk, Gross Margin Expansion, Strategic Divestiture, Board Refreshment

Related Tickers: CLX, PG, UL

TL;DR

**CLX is back on track, margins are up, and the board is getting a refresh – looks like a solid long-term play after the cyber hiccup.**

AI Summary

Clorox Co. demonstrated resilience in fiscal year 2025, advancing its IGNITE strategy despite lingering impacts from the August 2023 cyberattack and macroeconomic uncertainties. The company achieved over 200 basis points of gross margin expansion, returning to pre-pandemic levels through cost-savings programs and holistic margin management. Organic sales grew, and adjusted EPS showed solid growth. Strategic actions included the completed divestiture of the Better Health Vitamins, Minerals and Supplements business, positioning Clorox for more consistent, profitable growth. The company also progressed with its U.S. Enterprise Resource Planning (ERP) system transition and launched innovations across all major brands, supported by AI-enabled digital core. The Board of Directors underwent significant refreshment, welcoming five new directors over three years, including Gina Boswell, Stephen Bratspies, and Pierre Breber in fiscal year 2025, enhancing expertise in consumer goods, finance, and global operations. The short-term incentive plan payout was 80% due to net customer sales below target, while the long-term incentive plan paid out at 133% for the fiscal years 2022-2024 period, reflecting two years above and one year below expectations.

Why It Matters

Clorox's ability to expand gross margins by over 200 basis points and return to pre-pandemic levels, alongside solid adjusted EPS growth, signals strong operational recovery and efficiency for investors. The strategic divestiture of the Better Health VMS business indicates a focused approach to its core portfolio, which could lead to more predictable growth and better competitive positioning against rivals like Procter & Gamble and Unilever. For employees, the emphasis on digital transformation and a 'People First Culture' suggests a commitment to modernizing work environments and fostering engagement. Customers benefit from accelerated innovation cycles and a reinforced trust in brands, while the broader market sees a major consumer packaged goods player adapting to complex challenges and evolving its governance.

Risk Assessment

Risk Level: medium — The filing explicitly mentions 'remaining impacts from the August 2023 cyberattack' and 'macroeconomic and geopolitical uncertainties' as ongoing challenges, indicating persistent operational and market risks. While gross margin expanded by over 200 basis points, the short-term incentive plan payout of 80% was 'driven by net customer sales below target,' suggesting continued revenue challenges despite margin improvements. The ERP system transition also presents inherent execution risks.

Analyst Insight

Investors should consider Clorox's improved gross margins and strategic portfolio adjustments as positive indicators of operational recovery and future profitability. Monitor the progress of the U.S. ERP system transition and future net customer sales figures to assess sustained growth, as these are key to long-term value creation.

Executive Compensation

NameTitleTotal Compensation
Russell WeinerChief Executive Officer
Other Named Executive OfficersNamed Executive Officer

Key Numbers

Key Players & Entities

FAQ

What were Clorox's key financial achievements in fiscal year 2025?

In fiscal year 2025, Clorox achieved over 200 basis points of gross margin expansion, returning to pre-pandemic levels. The company also delivered solid adjusted EPS growth and saw its long-term incentive awards (PSUs) for fiscal years 2022-2024 pay out at 133%.

How is Clorox addressing its corporate governance and board composition?

Clorox has actively refreshed its Board, welcoming five new directors over the past three years, including Gina Boswell, Stephen Bratspies, and Pierre Breber in fiscal year 2025. The average Board tenure is approximately 5.7 years, and new chairs were appointed for the Audit Committee and Management Development and Compensation Committee in May 2025.

What is the IGNITE strategy and how is Clorox advancing it?

The IGNITE strategy is Clorox's long-term plan for purpose-driven growth, focusing on optimizing operations, innovating experiences, reimagining work, and evolving the portfolio. In fiscal year 2025, this included over 200 basis points of gross margin expansion, launching AI-enabled innovations, and divesting the Better Health Vitamins, Minerals and Supplements business.

What impact did the August 2023 cyberattack have on Clorox's fiscal year 2025 performance?

Clorox continued to navigate the 'remaining impacts from the August 2023 cyberattack' in fiscal year 2025. Despite these challenges, the company managed to grow organic sales and achieve solid adjusted EPS growth, demonstrating resilience in its operations.

How is executive compensation structured at Clorox and what were the recent payouts?

A substantial portion of executive compensation is variable, with 90% of the CEO's target compensation and 85% for other NEOs at risk. The short-term incentive plan for fiscal year 2025 paid out at 80% due to net customer sales below target, while the long-term incentive plan for fiscal years 2022-2024 paid out at 133%.

What strategic portfolio changes did Clorox make in fiscal year 2025?

In fiscal year 2025, Clorox completed the divestiture of its Better Health Vitamins, Minerals and Supplements business. This action is part of the company's strategy to strengthen its core portfolio and position itself for more consistent, profitable growth.

Who are the new directors on Clorox's Board and what expertise do they bring?

In fiscal year 2025, Clorox welcomed Gina Boswell, Stephen Bratspies, and Pierre Breber to its Board. Ms. Boswell brings extensive consumer goods experience, Mr. Bratspies adds operational and marketing expertise, and Mr. Breber offers deep financial and accounting knowledge, including experience as a former CFO.

What is Clorox's approach to sustainability and how is it governed?

Clorox integrates sustainability goals into its IGNITE strategy and conducts annual materiality assessments to align priorities with business and stakeholder needs. The company has a dedicated sustainability governance structure with oversight from the Board and management, and publishes an integrated annual report aligned with SASB and TCFD frameworks.

What are the key proposals for shareholders at the Clorox 2025 Annual Meeting?

Shareholders at the Clorox 2025 Annual Meeting will vote on three key proposals: the election of 11 director nominees, an advisory vote to approve executive compensation, and the ratification of Ernst & Young LLP as the independent registered public accounting firm.

How does Clorox ensure strong risk oversight at the Board level?

Clorox's Board maintains robust processes for overseeing key enterprise risks, receiving regular updates on risk and sustainability topics from management and experts. The Audit Committee specifically receives quarterly updates on cybersecurity and has oversight over enterprise risk management, ensuring comprehensive monitoring.

Risk Factors

Industry Context

Clorox operates in the consumer staples sector, facing competition from both large multinational corporations and smaller niche brands. The industry is characterized by brand loyalty, price sensitivity, and increasing consumer demand for sustainable and health-conscious products. Trends include digital transformation, supply chain resilience, and adapting to evolving consumer preferences.

Regulatory Implications

Clorox faces regulatory scrutiny related to product safety, environmental impact, and advertising practices. The company's focus on sustainability and evolving ESG regulations means ongoing compliance efforts are critical. The cyberattack also underscores the importance of data privacy and cybersecurity regulations.

What Investors Should Do

  1. [object Object]
  2. [object Object]
  3. [object Object]
  4. [object Object]

Key Dates

Glossary

IGNITE strategy
Clorox's long-term strategic plan focused on driving purpose-driven growth that maximizes economic profit and creates positive value for stakeholders. (This strategy guides the company's financial goals, sustainability initiatives, and overall business direction.)
DEF 14A
A filing with the U.S. Securities and Exchange Commission (SEC) that provides detailed information about a company's annual meeting of shareholders, including executive compensation, director nominees, and corporate governance matters. (This document provides the basis for the analysis of Clorox's governance and executive compensation practices.)
Gross margin expansion
An increase in the difference between revenue and the cost of goods sold, expressed as a percentage of revenue. (Indicates improved profitability at the product level, driven by cost savings and margin management, reaching pre-pandemic levels.)
Short-term incentive plan
An annual bonus plan designed to reward executives for achieving specific short-term financial and strategic goals. (The payout for fiscal year 2025 was 80% due to net customer sales falling below target, reflecting performance against short-term objectives.)
Long-term incentive plan (LTIs)
Compensation awarded to executives in the form of stock or other equity, designed to align their interests with shareholders and reward long-term company performance. (Performance share units (PSUs) paid out at 133% for the 2022-2024 period, indicating strong long-term performance.)
Named Executive Officers (NEOs)
The top executive officers of a company, typically including the CEO, CFO, and other key senior executives, whose compensation is disclosed in proxy statements. (Their compensation structure emphasizes pay-for-performance, with a significant portion at risk.)
Enterprise Resource Planning (ERP) system
Integrated software that manages core business processes, such as finance, HR, manufacturing, supply chain, services, procurement, and more. (The company's ongoing U.S. ERP system transition presents operational risks and opportunities for efficiency.)
Company multiplier
A factor used to adjust the payout of the short-term incentive plan based on overall company performance, such as sales or profitability. (A multiplier of 80% for fiscal year 2025 indicates that company performance, specifically net customer sales, was below target.)

Year-Over-Year Comparison

The previous filing likely detailed the ongoing impacts of the August 2023 cyberattack and the company's initial steps in its IGNITE strategy. This filing shows continued progress in margin expansion (over 200 basis points) and strategic divestitures, indicating a recovery trajectory. The Board has seen significant refreshment, with five new directors added over three years, including three in the most recent fiscal year, suggesting a focus on enhancing governance and expertise.

Filing Stats: 4,429 words · 18 min read · ~15 pages · Grade level 16.8 · Accepted 2025-10-07 16:16:34

Filing Documents

Executive Compensation

Executive Compensation 43 Proposal 2: Advisory Vote to Approve Executive Compensation 43 Compensation Discussion and Analysis 44

Executive Compensation Tables

Executive Compensation Tables 59 Equity Compensation Plan Information 78 Audit Committee Matters 79 Proposal 3: Ratification of Independent Registered Public Accounting Firm 79 Information About the Virtual Annual Meeting 81 Attending the Virtual Annual Meeting 86 Submitting Questions for the Virtual Annual Meeting 87 Appendix A: Management's Discussion and Analysis of Financial Condition and Results of Operations A-1 Appendix B: GAAP to Non-GAAP Reconciliation of Economic Profit B-1 Frequently Requested Information Our Corporate Purpose and Values, IGNITE Strategy and Integrated Sustainability Approach 14 Board Risk Oversight 29 Our Director Nominees 8 Sustainability Governance 32 Director Skills & Experience 9 Board Committees 35 Board Leadership Structure 25 Summary Compensation Table 59 The Clorox Company 2025 Proxy Statement > Proxy Summary 6 Proxy Summary This summary highlights information contained elsewhere in this proxy statement and does not contain all the information that you should consider. Please review the entire proxy statement before voting. Voting Matters and Voting Recommendations More information Board's voting recommendation PROPOSAL 1 Election of Directors Page 15 FOR EACH NOMINEE PROPOSAL 2 Advisory Vote to Approve Executive Compensation Page 43 FOR PROPOSAL 3 Ratification of Independent Registered Public Accounting Firm Page 79 FOR The Clorox Company 2025 Proxy Statement > Proxy Summary 7 Recent Highlights Here are some highlights since our 2024 Annual Meeting of Shareholders. New directors In May 2025, the board of directors (Board) welcomed a new director, Gina Boswell, who brings extensive executive, operational, and international experience in the consumer goods industry. Her appointment followed the Nominating, Governance, and Corporate Responsibility Committee's (NGCRC) thorough review of the Board's overall composition. Ms. Boswell jo

Executive Compensation

Executive Compensation Framework For more information, see the Compensation Discussion and Analysis section of this proxy statement. A substantial portion of target total direct compensation for our executives is variable, with 90% of target compensation at risk for our CEO and 85% of target compensation at risk on average for our other named executive officers. Base salary is the only fixed component of direct compensation. Component and Rationale CEO Proportion (1) NEO (2) Proportion (1) Performance Measures Performance Period Characteristics Base Salary Fixed pay to attract and retain talent, based on role, level of responsibilities, and individual performance. N/A N/A Fixed cash Annual Incentives Variable pay to incent and recognize performance in areas of short-term strategic importance. Annual net sales (50%) Net earnings (30%) Gross margin (20%) One Year Performance-based cash Long-Term Incentives (LTIs) Stock-based pay to incent and recognize performance in areas of long-term strategic importance, promote retention and stability, and align executives with shareholders. Economic profit Variation in underlying stock price due to overall business results Three Years (PSUs) PSUs and RSUs (1) Proportion represents the actual base salary, target annual incentive award, and grant date fair market value of LTI awards granted in fiscal year 2025 (with PSUs measured at target). Percentages may not total 100% due to rounding. Refer to the Summary Compensation Table on pg 59 for further details on actual compensation. (2) Represents the average of all NEOs active on June 30, 2025, other than the CEO. The Clorox Company 2025 Proxy Statement > Our Company 1 3 Our Company The Clorox Company 2025 Proxy Statement > Our Company 14 IGNITE Strategy and Integrated Sustainability Approach Clorox's IGNITE strategy is our long-term strategic plan to drive purpose-driven growth that maximizes economic profit and at

View on Read The Filing